
Arialys Therapeutics
Operator of a clinical-stage biotechnology company intended to pioneer new precision medicines for autoimmune neuropsychiatric diseases. The company specializes in the field of neuroscience and charac...
Valuation
$112M
Latest known
Share Price
N/A
Total Raised
$72M
Last Round
N/A